Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
A UKIPO report reveals gradual growth in female inventors in UK patent filings from 1997–2024. Despite progress, women remain underrepresented across sectors and inventor teams.
Minutes from T 873/24 suggest a new referral to the Enlarged Board of Appeal on whether G 1/24—requiring consultation of the description when interpreting claims—also applies to added subject matt
For International Women’s Day, Boult highlights our commitment to women in IP, supporting career growth through IP Inclusive and the new Women in IP mentoring scheme.
The National Energy System Operator 2025 review shows renewables supplying 44% of UK electricity. Yet patent filings tell a different story, with gas leading innovation despite wind topping generation
Board of Appeal decision T 700/25 casts doubt on J 1/24’s limited path to filing divisionals after grant, reaffirming that applicants should file before the parent patent grants.
In G1/25, the EPO President confirms that amended claims must be matched by description amendments under Article 84 EPC, in both examination and opposition.
UK IPO to raise patent, trade mark and design fees by 25% from 1 April 2026. Early renewals in some cases can secure current rates. Portfolio planning now essential.
Overview of EMA-defined biosimilars, EU IP protections and limits including Bolar exemption, SPC manufacturing waiver, skinny labelling and loss of exclusivity strategies.
The UK Supreme Court has reshaped software patent assessment, moving away from Aerotel toward greater EPO harmonisation and confirming that an ANN is a “program for a computer.”
Two recent invalidity decisions show the risks of relying on online marketplace listings as prior art and demonstrate how design freedom shapes assessments of novelty and individual character.
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.
The UPC Court of Appeal has clarified its inventive step framework. We compare the UPC’s approach with the EPO’s Problem-Solution analysis, highlighting key similarities and differences.
An analysis of T-628/24, where the General Court upheld revocation of Lego’s EU design for a modified plate, questioning how informed users and subtle design differences are assessed in modular syst
The Brooklyn Beckham trade mark raises key questions about who controls a celebrity’s own name, the limits of the “own name” defence and the long-term risks of name-based trade mark registration
We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolving patent strategies shaping the sector.
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential burdens and confirmed sales via distributors can suf
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they reached opposite outcomes in parallel proceedings
Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
